Unlimited Provider Access + Weight Loss Coaching Your healthcare provider will help you find the right dose of a GLP-1 Medication including Semaglutide (same active ingredient as Wegovy*, and Ozempic* ), to achieve healthy weight loss
Cerebral perfusion Converging evidence strongly supports the notion that changes in CBF precede structural and functional deficits associated with neurodegeneration, and may be amongst the earliest indicators of ADRD risk (Jack et al., 2010)
The 12mg maximum is lower than tirzepatide but achieves greater efficacy, demonstrating that three receptor targets provide synergistic effects beyond what raw dosing would suggest
You can choose whether the NHS uses your data for research and planning at You can find out more about how data about you has been processed and your rights, by visiting the the NHS Digital website ( ascend-plus)
Key finding: AOD 9604 sustained 7.1 kg weight reduction at 52 weeks with continued preferential fat loss
10.1038/s41366-024-01500-y 9 BuckeridgeC.CobainS.BaysH